VTGN - Vistagen Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.43 0.14 (3.16%) 0.0 (0.0%) 0.02 (0.33%) 0.04 (0.88%) 0.16 (3.61%) 0.1 (2.24%) -0.11 (-2.45%) 0.1 (2.23%)

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.47
Diluted EPS:
-0.47
Basic P/E:
-9.7234
Diluted P/E:
-9.7234
RSI(14) 1m:
73.33
VWAP:
4.57
RVol:

Events

Period Kind Movement Occurred At

Related News